Stock Report

All about this stock under one free report Last Updated: 17-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Graphite Bio Inc (GRPH)

Stock Card factsheet share-fund-plan-icon

$22.26

$0.00 (0.00%)

As on 22-Mar-2024 09:30EDT

Market cap

info icon

$185 Mln

Revenue (TTM)

info icon

$10 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Graphite Bio Inc (GRPH) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 22.26 High: 22.26

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-79 Mln

  • ROEROE information

    -0.5 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -15.7

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $3.2

  • EPSEPS information

    $-2.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    58,236,900

5 Years Aggregate

CFO

$-239.58 Mln

EBITDA

$-312.99 Mln

Net Profit

$-294.59 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Graphite Bio Inc (GRPH)
21.4 6.0 35.3 36.5 -- -- --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 22-Mar-2024  |  *As on 15-May-2026  |  #As on 26-Oct-2023
Company
2023
2022
Graphite Bio Inc (GRPH)
-21.1 -73.3
S&P Small-Cap 600
13.9 -17.4
BSE Sensex
18.7 4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Graphite Bio Inc (GRPH)
22.3 185.2 0.0 -124.7 -494.4 -52 -- 1.0
Homology Medicines (FIXX)
0.9 3.0 1.2 -113.0 -7,739.1 -90 -- 0.0

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Graphite Bio Inc (GRPH)

As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc., in a reverse merger transaction. Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in...  the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.  Read more

  • President, CEO, COO, Principal Executive, Financial & Accounting Officer and Director

    Ms. Kimberlee Cobleigh Drapkin CPA

  • President, CEO, COO, Principal Executive, Financial & Accounting Officer and Director

    Ms. Kimberlee Cobleigh Drapkin CPA

  • Headquarters

    South San Francisco, CA

  • Website

    https://graphitebio.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Graphite Bio Inc (GRPH)

The share price of Graphite Bio Inc (GRPH) is $22.26 (NASDAQ) as of 22-Mar-2024 09:30 EDT. Graphite Bio Inc (GRPH) has given a return of 36.48% in the last 1 years.

Since, TTM earnings of Graphite Bio Inc (GRPH) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2023
-1.22
0.83
2022
-1.92
0.62
2021
-11.12
1.73
2020
--
--
2019
--
--

The 52-week high and low of Graphite Bio Inc (GRPH) are Rs -- and Rs -- as of 17-May-2026.

Graphite Bio Inc (GRPH) has a market capitalisation of $ 185 Mln as on 01-Apr-2024. As per SEBI classification, it is a Small Cap company.

Before investing in Graphite Bio Inc (GRPH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.